Kapruvia 50 µg/ml, Injektionslösung

7680686530027 CH-68653 Injektionslösung
Kapruvia 50 µg/ml, Injektionslösung
Kapruvia 50 µg/ml, Injektionslösung
Kapruvia 50 µg/ml, Injektionslösung
1 / 3
google

Article details

Package size
12 x 1 ml
Selling units
12
Measure
Durchstechflasche(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
19/07/2024
Summary of Product Characteristics
Français
19/07/2024
Summary of Product Characteristics
Italien
19/07/2024

Detailed composition

Substance Quantity Type Category
(N/A)
50.0 UG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
3.3 MG Substance HBESI

Reimbursement information

Public price
CHF 358.85
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/01/2024

Authorization holder

Vifor Fresenius Medical Care

9014 St. Gallen

Authorization information

Swissmedic authorization number
68653
Drug name
Kapruvia, Injektionslösung
Galenic form
LSINJ
ATC Code
V03AX04
Authorization status
Z
Dispensing category
B
First authorization
16/08/2022
Authorization expiration date
15/08/2027
IT Number
05.99.0.
Domain
Human medicine
Field of application
Behandlung von Pruritus in Zusammenhang mit chronischen Nierenerkrankungen bei erwachsenen Patienten unter Hämodialyse

Package details

Description (FR)
KAPRUVIA sol inj 0.05 mg/ml 12 flac 1 ml
Description (DE)
KAPRUVIA Inj Lös 0.05 mg/ml 12 Durchstf 1 ml
Market launch
16/08/2022
Narcotic (BTM)
No

Other package sizes (1)

KAPRUVIA sol inj 0.05 mg/ml 3 flac 1 ml
3 x 1 ml DUR
GTIN: 7680686530010
View